drugset / Trial / NCT02335060

N-acetylcysteine Effects on Tetrahydrocannabinol

NCT02335060

Phase 0 Terminated 5 enrolled Yale University
RandomizedCrossoverQuadruple-blindBasic science

Summary

The overall purpose of this study is to examine the effect of N-acetylcysteine (NAC) on the acute effects of Delta-9-tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with NAC and then assessing their responses to THC.

Timeline

Start
2014-05-02
Primary completion
2014-09-16
Completion
2014-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 0.036 mg/kg Intravenous
Subject N-acetylcysteine Small molecule Oral

Indications

No indication recorded.